De-novo sequencing of nucleic acids
AssigneeRoche Molecular Systems, Inc.
InventorsUwe Kobold, Dieter Heindl, Herbert von der Eltz, Ivo Gut, Christoph Steinbeck
Life of this patent
Estimating the term…
Abstract
The present invention is directed to an improved analysis procedure for the comparative sequencing of nucleic acids using multistage mass spectrometry. More precisely, the invention is directed to a method enabling the de-novo sequencing of nucleic acid molecules using multistage mass spectrometry.
Claims55
A method for the sequencing of a target nucleic acid comprising:
- a) performing a multistage mass spectrometry, comprising
- i) ionizing said target nucleic acid,
- ii) measuring the mass of the ionized target nucleic acid,
- iii) determining the base composition corresponding to the mass of said ionized target nucleic acid,
- iv) fragmenting said ionized target nucleic acid by a collision induced dissociation (CID) and
- v) measuring the corresponding mass spectrum of the CID fragments, and
- b) comparing the measured CID mass spectrum of the target nucleic acid measured in step v) with a plurality of calculated CID mass spectra, wherein each of said calculated CID mass spectra correspond to a base sequence having the base composition determined in step iii),
- wherein the comparison of the measured CID mass spectrum with the calculated CID mass spectra is performed by an optimization algorithm,
- wherein said optimization algorithm compares said measured CID mass spectrum successively with said plurality of calculated CID mass spectra and determines a respective score value for each comparison, said score value representing the degree of consistency between said measured CID mass spectrum and said calculated CID mass spectra, and
- wherein the base sequence corresponding to the calculated CID mass spectra yielding the best score value is selected as the base sequence of said target nucleic acid.
A program of instructions executable by a computer-implemented system for the sequencing of a target nucleic acid based on the comparison of a measured CID mass spectrum of said target nucleic acid with a plurality of calculated CID mass spectra,
- wherein the base composition of said target nucleic acid is known and
- wherein each of said calculated CID mass spectra corresponds to a base sequence having the base composition of said target nucleic acid in order to automatically determine the base sequence of the target nucleic acid
- wherein said comparison of the measured CID mass spectrum with the calculated CID mass spectra is performed by an optimization algorithm,
- wherein said optimization algorithm compares said measured CID mass spectrum successively with said plurality of calculated CID mass spectra and determines the respective score value of each comparison, said score value representing the degree of consistency between said measured CID mass spectrum and said calculated CID mass spectra, and
- wherein the base sequence corresponding to the calculated CID mass spectra yielding the best score value is selected as the base sequence of said target nucleic acid.
Dependencies are inferred from the claim text.